Article Text

Download PDFPDF

Peritoneal amyloidosis with myopathy in primary systemic (AL) amyloidosis
Free
  1. Ali Al-Adhami1,
  2. Kate Steiner2,
  3. Spencer Ellis3
  1. 1Wirral University Teaching Hospital NHS Foundation Trust, Upton, UK
  2. 2Department of Radiology, Lister Hospital, Stevenage, UK
  3. 3Department of Rheumatology, Lister Hospital, Stevenage, UK
  1. Correspondence to Dr Kate Steiner, kate.steiner{at}nhs.net

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Description

We present an unusual case of primary systemic amyloidosis presenting with myopathy and peritoneal amyloid deposition. Peritoneal amyloid is a rare disease with few published cases.1

An 85-year-old man was referred to rheumatology with walking difficulties and elevation of serum creatine kinase (CK). Initial tests revealed elevated erythrocyte sedimentation rate (ESR) 76 mm/hour; normal C reactive protein (CRP) and serum CK of 525 IU/L. Antinuclear and extractable nuclear antibodies (including anti-Jo1) were negative. Investigations for myopathy included MRI Stir sequence (figure 1) demonstrated increased signal in the hip adductors bilaterally, consistent with symmetrical myositis. CT scan of the chest, abdomen and pelvis, requested to exclude occult cancer, revealed diffuse infiltration of the mesentery and retroperitoneal fat (figure 2), despite lack of abdominal symptoms. This appearance was initially considered suspicious of malignancy without an obvious primary lesion; however, mesenteric biopsy reported only hyaline fatty sclerosis.

Figure 1

Axial stir MRI of both thighs demonstrating increased signal within the hip adductors (white arrows) in keeping with a diffuse symmetrical myositis.

Figure 2

Axial CT image demonstrating diffuse mesenteric thickening/infiltration (white arrow).

On follow-up, the patient described spontaneous bruising. Serum protein electrophoresis was initially normal, although urine for Bence-Jones protein showed Lambda light chain of 0.03 g/24 hours. The possibility of amyloidosis was considered, and Congo Red stain of the existing mesenteric biopsy was requested, which was positive.

Bone marrow biopsy showed 15% plasma cells, and serum analysis demonstrated raised free light Lambda chain of 102 mg/L. The final diagnosis was systemic AL (lambda-type) amyloidosis, with muscle infiltration mimicking myositis.

Two patterns of peritoneal amyloid have been described on imaging; diffuse and nodular types. Our patient had the diffuse pattern of peritoneal amyloid.2

Learning points

  • Amyloidosis is a multisystem disease that can present in unusual ways and with a wide range of clinical features. A high index of suspicion for the presence of abnormal plasma proteins should be maintained in any patient presenting with a combination of normal CRP and significantly raised ESR.

  • Gastrointestinal tract involvement occurs in only 8% of patients with systemic AL amyloidosis, most frequently involving the small bowel but peritoneal involvement is much more rarely reported.

  • Differentiation of peritoneal amyloidosis from infectious or malignant diseases involving the peritoneum and greater omentum is difficult, making a biopsy essential when possible.

Acknowledgments

The author thanks Dr Ellis for his tremendous support to get this case published. The author likes to extend gratitude to Dr Steiner's contribution to the case. Dr Al-Adhami has participated in setting the basis for this publication.

References

View Abstract

Footnotes

  • Contributors KS provided input in relation to the images. SE has tremendously contributed to this publication by providing essential information and radiological images. AA efforts are indispensable and continuously contributed in collecting the data and writing the case, in addition to his support with previous submissions.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.